“This is the end of a really long running case whose chief aim was to compensate women who were subjected to a very misleading marketing campaign,” Beasley Allen’s David Byrne told Law.com on Wednesday. “These products were sold to all women as this fountain of youth pill with claimed but unproven benefits.”